The Nurse’s Expanding Role in Treating Psoriatic Conditions: Improving Outcomes and Patient Satisfaction
  • CE

This interactive video program—tailored for nursing professionals and divided into 3 concise segments—reviews how to assess QoL, manage comorbidities, and design effective treatment approaches in patients with psoriasis or psoriatic arthritis.
Lakshi M. Aldredge, MSN, ANP-BC, DCNP
Registered Nurses: 1.3 Nursing contact hours
Registered Nurse Practitioners: 1.3 Nursing contact hours
Released: August 20, 2019 Expiration: August 19, 2020
Multimedia The Nurse’s Expanding Role in Treating Psoriatic Conditions: Improving Outcomes and Patient Satisfaction
This program is divided into short segments. After reviewing all segments, click the Claim Credit button to complete the CME/CE posttest and evaluation.
Assessing Health-Related Quality of Life (16 mins)
Learn to recognize how psoriatic disease affects daily life. Practice asking standardized questions, or use validated tools to elicit the information you need for an accurate, regular assessment of QoL.
Launch Assessing Health-Related Quality of Life (16 mins)
Screening and Referrals for Comorbidities (26 mins)
Almost every major organ in the body can demonstrate inflammatory components related to psoriatic disease. Discover which age-appropriate comorbidity screenings are essential for this population.
Launch Screening and Referrals for Comorbidities (26 mins)
Implementing Effective Therapeutic Approaches (30 mins)
Review the available therapeutic classes for patients with psoriatic disease—including key safety considerations—and how shared decision-making can enhance treatment efficacy.
Launch Implementing Effective Therapeutic Approaches (30 mins)

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Investigate the impact of psoriatic disease on patients’ comfort level, daily functioning, and work/social activities in order to determine appropriate QoL treatment goals
  • Incorporate appropriate screening, testing, and referral protocols for comorbidities into the management of patients with psoriatic disease
  • Implement effective treatment approaches for patients with moderate to severe psoriatic disease through shared decision-making


Provided by the Annenberg Center for Health Sciences at Eisenhower

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Supported by educational grants from

Information on this Educational Activity

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME/CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:


Lakshi M. Aldredge, MSN, ANP-BC, DCNP

Nurse Practitioner
Dermatology Service
VA Portland Health Care System
Portland, Oregon

Lakshi M. Aldredge, MSN, ANP-BC, DCNP, has disclosed that she has received consulting fees from AbbVie, Celgene, Lilly, Novartis, Regeneron, Sanofi Genzyme, and Sun Pharma and fees for non-CME/CE services for AbbVie, Lilly, Novartis, Regeneron, Sanofi Genzyme, and Sun Pharma.


Megan K. Murphy, PhD

Scientific Director

Megan K. Murphy, PhD, has no relevant conflicts of interest to report.
Tiffany Hensley-McBain, PhD

Clinical Editor

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.
Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

The PIM planners and managers have nothing to disclose.

Charles E. Willis, Director of Continuing Education; Amanda Sewell, MBA, Manager of Continuing Education and Melissa Velasquez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for nurse practitioners, registered nurses, and other healthcare providers who care for patients with PsO and PsA.


The goal of this activity is to improve nurses’ competence in caring for patients with psoriatic conditions in order to achieve optimal clinical outcomes and patient satisfaction.

Nursing Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

1.3 contact hours may be earned for successful completion of this activity.

Nurse Practitioner Continuing Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options. The Annenberg Center for Health Sciences at Eisenhower is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207

Credit Designation

This activity is approved for 1.3 contact hours of continuing education (which includes 0.4 hour(s) of pharmacology). Program ID # 5782

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.3 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 20, 2019, through August 19, 2020:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Downloadable slides on managing psoriatic conditions to improve quality of life, including treatment considerations and comorbidity screening

Lakshi M. Aldredge, MSN, ANP-BC, DCNP Released: August 20, 2019

Point-of-care PDF on therapies for psoriasis and psoriatic arthritis: Review dose, monitoring, adverse events for topicals, oral systemics, biologics.

Lakshi M. Aldredge, MSN, ANP-BC, DCNP Released: August 2, 2019

Despite demonstration of comparable efficacy and safety between biosimilars and their originators, some patients avoid this treatment switch. Here’s my take on steps to assuage unfounded patient fears.

Jonathan Kay, MD Released: February 13, 2018

Watch our recent quiz game on biosimilars in rheumatologic conditions.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: November 28, 2017 Expiration: November 27, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?